Comparison of two adjuvant hormone therapy regimens in patients with high-risk localized prostate cancer after radical prostatectomy: primary results of study CU1005

The role of adjuvant hormonal therapy and optimized regimens for high-risk localized prostate cancer after radical prostatectomy remains controversial. Herein, the clinical trial CU1005 prospectively evaluated two regimens of maximum androgen blockage or bicalutamide 150 mg daily as immediate adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kun, Qin, Xiao-Jian, Zhang, Hai-Liang, Dai, Bo, Zhu, Yao, Shi, Guo-Hai, Shen, Yi-Jun, Zhu, Yi-Ying, Ye, Ding-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854103/
https://www.ncbi.nlm.nih.gov/pubmed/26323560
http://dx.doi.org/10.4103/1008-682X.160884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854103/
https://www.ncbi.nlm.nih.gov/pubmed/26323560
http://dx.doi.org/10.4103/1008-682X.160884

Ejemplares similares